Pericardial effusion and complications

Article written and reviewed by Dr Luca Moretti

The pericardial cavity normally contains a small amount of fluid that facilitates sliding of the surfaces during the cardiac cycle. When production, reabsorption or structural integrity is altered, a pathological collection may form. A pericardial effusion is therefore a finding with many possible causes, not an etiologic diagnosis and not a synonym for pericarditis.

The clinical significance depends mainly on rate of accumulation, distribution and consequences for filling. A large collection that progresses slowly may be tolerated, whereas a small amount introduced rapidly into a poorly distensible sac may compromise circulation. The contents may be serous, inflammatory, bloody or chylous; more rarely, air is present. The nature of the material guides the investigation but does not replace hemodynamic assessment.

Complications range from recurrence of the collection to tamponade and persistence of a constrictive restriction. A useful assessment distinguishes three questions: whether the heart is compressed, which mechanism produced the accumulation, and which strategy can prevent its progression. These questions remain valid both for an incidental finding and in an unstable patient.

Mechanisms of accumulation and main etiologic settings

The fluid balance depends on exchanges across the surfaces and lymphatic drainage. Increased permeability during inflammation promotes exudation, whereas impaired reabsorption may produce a collection even without pain or fever. Elevated venous pressure and systemic abnormalities further alter these exchanges. To understand a pericardial effusion, therefore, it is not enough to look for pericarditis: circulation, metabolism and the thoracic structures involved in drainage must also be considered.

The inflammatory causes include infections and immune-mediated processes, with a distribution that differs according to the epidemiologic context and immune status. Fluid may be only one component of a syndrome dominated by pain and systemic inflammatory response. A purulent collection requires a specific etiologic and drainage pathway, whereas idiopathic inflammatory disease may respond to treatment for pericarditis. The distinction should precede prolonged use of therapies that modify the immune response.

The systemic diseases may alter production and reabsorption without an obvious painful serositis. Renal failure, heart failure and hypothyroidism are examples with different mechanisms. hypothyroidism-related pericardial effusion may accumulate slowly and requires correction of the hormonal deficiency, while keeping any urgent indication for decompression separate. The presence of a known systemic disease does not, however, make it unnecessary to search for other causes when the presentation or course is atypical.

The oncologic setting includes pericardial infiltration, lymphatic obstruction, treatment effects and conditions unrelated to the tumor. A collection in a person with cancer is not automatically malignant. Cytology and, when indicated, biopsy may clarify its origin, while imaging and the clinical course define extent and impact. Correct attribution changes staging, prognosis and treatment; therefore, judgment must integrate the oncologic history with the data actually obtained from the pericardium.

The pericardial bleeding may follow trauma, procedural perforation, vascular injury or cardiac rupture, or may complicate a pre-existing disease. In hemopericardium the priority is to recognize compression and the source of bleeding. A merely serosanguineous fluid does not by itself identify active hemorrhage, nor does it prove malignancy. Anticoagulation and coagulopathy may facilitate the process, but their presence should not prevent the search for a correctable structural lesion.

The unusual collections require targeted anatomic reasoning. chylopericardium indicates entry of lipid-rich lymph and may result from lymphatic abnormalities, surgery or obstruction; pneumopericardium instead consists of air within the sac, which may occur after trauma, ventilation, procedures or pathological communications. These conditions share the risk of compression with effusion, but require investigation and treatment of the cause that cannot be inferred from the model of inflammatory pericarditis alone.

From collection to hemodynamic compromise

The pressure-volume curve explains why size and danger are not equivalent. As long as the sac adapts, increasing volume produces limited pressure changes; once distensibility reserve is exhausted, further increases may produce a rapid rise in pressure. The rate of accumulation changes the capacity for adaptation. Fibrosis, adhesions and previous procedures also alter pericardial behavior, making any volume threshold applied indiscriminately to all patients unreliable.

In cardiac tamponade, external pressure impairs filling until cardiac output is reduced. Tachycardia and vasoconstriction may initially preserve arterial pressure, while functional reserve and perfusion decline. Therefore, a normotensive patient may have clinically significant compression. Diagnosis arises from concordance among symptoms, examination and imaging; it cannot be excluded because a single component of the classic presentation is absent.

The volume status modifies chamber filling pressure and its relationship to pericardial pressure. Dehydration or rapid fluid removal may unmask a previously compensated restriction. Conversely, high right-sided pressures, as in some forms of pulmonary hypertension, may attenuate the usual signs of collapse. Interpretation of findings must therefore include the circulatory and respiratory situation, avoiding conversion of a useful echocardiographic criterion into an absolute rule.

The regional distribution is particularly relevant after surgery, trauma and organized inflammation. A pocket of fluid or a clot may selectively compress an atrium or ventricle, with signs different from circumferential tamponade. Incomplete visualization of the collection may create false reassurance. In discordant cases, additional imaging should address the precise anatomic concern, while in an unstable patient the team able to intervene should be involved without waiting for perfect characterization.

The constrictive restriction may accompany or follow accumulation. In effusive-constrictive pericarditis removal of the fluid does not eliminate all restriction to filling, because a tissue component remains. Persistent congestion after drainage therefore does not always mean recurrence of the collection. The pericardium and myocardium must be evaluated, distinguishing potentially reversible inflammation, fibrosis and concomitant cardiac dysfunction before choosing further procedures.

The organ consequences result from reduced cardiac output and venous congestion: worsening renal function, hepatic injury, fatigue and loss of independence may appear before overt collapse. Severity should be assessed over time, observing changes in perfusion and function in addition to the millimeters of effusion. This dynamic interpretation makes it possible to act on a correctable complication and avoid automatically attributing deterioration to known cancer, renal or cardiac disease.

Clinical assessment and the role of imaging

An incidental finding requires confirmation and contextualization, not necessarily intervention. History, symptoms, known diseases and comparison with previous studies define the probability of causes and urgency. Progressive dyspnea, pain, fever, syncope or reduced urine output change the level of concern. The date of first recognition does not always coincide with the onset of accumulation: a collection discovered today may be chronic, whereas a recent normal study suggests a different dynamic.

Echocardiography is the initial reference method for localizing fluid, estimating its extent and analyzing its consequences for filling. Measurement of the echo-free space is integrated with chamber collapse, respiratory flow variation and behavior of the inferior vena cava. The report should describe distribution, any septations or clots, and associated cardiac function. The number of millimeters facilitates comparisons but does not replace a clinical conclusion about hemodynamic significance.

Laboratory testing is selected to distinguish inflammatory activity, systemic disorders and the risk associated with procedures or medications. Complete blood count, C-reactive protein, renal function and, when indicated, thyroid testing and troponin are frequent components. No standard panel identifies every cause. Microbiologic and immunologic studies should follow the clinical suspicion, because incidental positive results can be mistaken for explanations without a demonstrated causal relationship and lead to inappropriate treatment.

CT clarifies the anatomy of collections, calcifications, air, masses and mediastinal relationships. Cardiac MRI adds tissue characterization, inflammatory activity and information on constrictive physiology. The methods are complementary, not mandatory steps for every small effusion. A patient with obvious compression and instability requires timely treatment; advanced studies are used when the result can guide access, etiologic diagnosis or subsequent strategy without delaying stabilization.

Analysis of the contents is performed when drainage is indicated. Cytology, microbiology and specific tests may distinguish tumor infiltration, infection or lymphatic leakage. Macroscopic appearance is only a clue: blood does not necessarily mean cancer, and milky fluid requires confirmation that it is chylous. Biochemistry also must be interpreted cautiously, because criteria developed for pleural effusions cannot automatically be applied to the pericardial cavity with the same meaning.

The integrated assessment should produce an operational conclusion: a stable collection without urgency, inflammatory disease to treat, an etiologic suspicion to clarify, or compression to relieve. Conditions may overlap and require parallel interventions. A provisional diagnosis must remain open to revision if the course changes. Failure to improve, rapid reaccumulation or the appearance of new systemic signs are reasons to reassess the cause, not merely to repeat the initial treatment automatically.

Principles of treatment and choice of procedure

Etiologic treatment is the foundation when a correctable cause exists. A collection associated with inflammation is managed according to the type of pericarditis, whereas endocrine abnormalities, inadequate dialysis or congestion require specific interventions. There is no universal drug capable of eliminating every effusion. Fluid reduction may be slow even after the mechanism is corrected, so clinical response and hemodynamic stability should be considered together with the echocardiographic trend.

Scheduled observation is appropriate in selected stable patients after adequate assessment of the cause and risk. Large chronic idiopathic collections without inflammation do not automatically require preventive drainage: contemporary studies support a conservative approach in the absence of other indications. This choice nevertheless requires accessible follow-up and instructions for new symptoms. It cannot be extrapolated to rapidly enlarging effusions, suspected infections, possible hemorrhage or clinically significant compression.

Pericardiocentesis may have therapeutic and diagnostic purposes, with imaging guidance and selection of the safest route. Prolonged drainage through a catheter is useful in certain settings to evacuate the collection and monitor output. A localized, clotted or poorly accessible effusion may require a different approach. The choice does not depend only on the amount of fluid, but on anatomy, nature of the contents, rate of evolution and available expertise.

Surgical drainage is particularly relevant when clot evacuation, treatment of the bleeding source, tissue sampling or control of complex collections is required. A window creates a drainage route and may reduce selected recurrences, but it does not cure every cause or correct diffuse constriction. Pericardiectomy, window and simple evacuation have different aims. Precise description of the problem avoids proposing a more invasive procedure without a benefit consistent with the mechanism.

Urgent situations require a strategy proportionate to the cause. In tamponade due to fluid, decompression is central; when cardiac rupture, aortic injury or active bleeding is present, definitive treatment may be surgical and percutaneous drainage must be evaluated in context. Tension air can also compress the heart. Measures to support perfusion do not replace correction of the obstruction and must avoid interventions that worsen venous return.

Post-procedure monitoring checks perfusion, ventricular function, residual and new collections. Subsequent deterioration may result from bleeding, procedural injury, recurrence, persistent restriction or dysfunction after decompression. Not all complications are reflected by the volume drained alone. Management should include clinical surveillance and imaging when needed, together with treatment of the underlying disease, because technically successful decompression does not always coincide with definitive resolution of the pericardial problem.

Prognosis, recurrences and continuity of surveillance

Prognosis depends mainly on the cause and the presence of hemodynamic compromise. A small stable idiopathic effusion has a different meaning from a malignant, purulent or hemorrhagic collection, even when the dimensions at the time of examination are similar. The immediate risk of tamponade must be distinguished from the long-term prognosis of the underlying disease. This separation helps explain why urgent intervention may be useful even in a complex illness and why not every finding requires a procedure.

Recurrence of fluid may reflect persistence of the mechanism, reactivation of inflammation or inadequate drainage. After drainage, new accumulation should be compared with symptoms, rate and previous diagnostic findings. Repeating the same procedure may be appropriate in some cases, whereas in others an etiologic or anatomic change in strategy is needed. A collection that returns is not automatically a technical failure, but rather a finding to interpret within the course of the disease.

Complications of the cause may differ from those of compression. Prolonged chylous loss has nutritional and immunologic consequences; infection may lead to organization and constriction; a hemorrhagic lesion requires control of the source. Follow-up therefore must go beyond measuring fluid. Echocardiographic improvement is not enough if fever, protein loss, congestion or signs of systemic progression continue, as these may indicate an ongoing process.

The frequency of follow-up is adapted to size, stability, cause and access to care. After a new diagnosis, observing the course over a short interval may be useful before defining the collection as stable; in selected chronic forms, intervals may be longer. No schedule eliminates the need to reassess new symptoms. A minimal incidental collection without risk factors may not require the same surveillance as persistent moderate or large effusions.

Clinical communication should report the established or suspected cause, size and distribution, inflammatory activity, hemodynamic impact and goals of the plan. This summary is more useful than the single label of effusion. The patient should know which changes require attention, especially progressive dyspnea, syncope, new pain, fever or reduced urine output. A conservative choice becomes safe when accompanied by the possibility of follow-up and understandable instructions on management of worsening.

Functional recovery is assessed in relation to exercise capacity, symptoms and the underlying disease. Restrictions specific to active pericarditis should not be applied indiscriminately to every small non-inflammatory finding; at the same time, a patient with compression or associated dysfunction requires a cautious return to activity. The aim of surveillance is to maintain stability, recognize evolution and treat correctable mechanisms, avoiding both preventive procedures without indication and delays in the face of a hemodynamic complication.

References
1. Schulz-Menger J et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. European Heart Journal. 2025;46(40):3952-4041.
2. Klein AL et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC: Cardiovascular Imaging. 2024;17(8):937-988.
3. Adler Y et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2015;36(42):2921-2964.
4. Roberts WC. Pericardial heart disease: its morphologic features and its causes. Proceedings (Baylor University Medical Center). 2005;18(1):38-55.
5. Spodick DH. Acute cardiac tamponade. New England Journal of Medicine. 2003;349(7):684-690.
6. Sagristà-Sauleda J et al. Effusive-constrictive pericarditis. New England Journal of Medicine. 2004;350(5):469-475.
7. Mori S et al. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardio-Oncology. 2024;10:8.
8. Rosen RJ, Valeri AM. Management of Patients with Kidney Failure and Pericarditis. Clinical Journal of the American Society of Nephrology. 2023;18(2):270-272.
9. Saab J et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. Cancer Cytopathology. 2017;125(2):128-137.
10. Ben-Horin S et al. The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. American Journal of Medicine. 2005;118(6):636-640.
11. Verma B et al. Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review. Heart. 2023;109(17):1281-1285.
12. Cummings RG et al. Pneumopericardium resulting in cardiac tamponade. Annals of Thoracic Surgery. 1984;37(6):511-518.
13. Imazio M et al. Outcomes of idiopathic chronic large pericardial effusion. Heart. 2019;105(6):477-481.
14. Lazaros G et al. Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions. American Journal of Cardiology. 2020;126:89-93.
15. Sarode K et al. Pericardial Decompression Syndrome: A Comprehensive Review of a Controversial Entity. International Journal of Angiology. 2024;33(3):139-147.